1. Home
  2. CAVA vs AXSM Comparison

CAVA vs AXSM Comparison

Compare CAVA & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CAVA Group Inc.

CAVA

CAVA Group Inc.

HOLD

Current Price

$66.58

Market Cap

10.6B

ML Signal

HOLD

Logo Axsome Therapeutics Inc.

AXSM

Axsome Therapeutics Inc.

HOLD

Current Price

$206.68

Market Cap

11.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAVA
AXSM
Founded
2006
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6B
11.2B
IPO Year
2023
2015

Fundamental Metrics

Financial Performance
Metric
CAVA
AXSM
Price
$66.58
$206.68
Analyst Decision
Buy
Strong Buy
Analyst Count
23
17
Target Price
$91.00
$211.12
AVG Volume (30 Days)
3.2M
643.5K
Earning Date
05-12-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.56
EPS
0.39
N/A
Revenue
$1,179,664,000.00
N/A
Revenue This Year
$25.71
$57.24
Revenue Next Year
$20.57
$55.88
P/E Ratio
$173.77
N/A
Revenue Growth
22.41
N/A
52 Week Low
$43.41
$112.90
52 Week High
$98.79
$260.19

Technical Indicators

Market Signals
Indicator
CAVA
AXSM
Relative Strength Index (RSI) 46.53 N/A
Support Level $60.12 N/A
Resistance Level $68.88 N/A
Average True Range (ATR) 2.84 0.00
MACD 0.20 0.00
Stochastic Oscillator 45.85 0.00

Price Performance

Historical Comparison
CAVA
AXSM

About CAVA CAVA Group Inc.

Cava Group Inc owns and operates a chain of restaurants. It operates a Mediterranean-inspired fast-casual restaurant brand offering menu items. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: i) CAVA: It includes the operations of all company-owned CAVA restaurants, and ii) CAVA Foods: It includes the production of dips, spreads, and certain dressing bases used in CAVA restaurants as well as sales from the Company's consumer packaged goods business. The company generates the majority of its revenue from the CAVA segment.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: